These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22885618

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W, Brasch J, Cornely OA, Effendy I, Friese K, Ginter-Hanselmayer G, Hof H, Mayser P, Mylonas I, Ruhnke M, Schaller M, Weissenbacher ER.
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
    Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L.
    Akush Ginekol (Sofiia); 2005 Mar; 44 Suppl 2():25-7. PubMed ID: 16028400
    [Abstract] [Full Text] [Related]

  • 4. Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
    Baltch AL, Bopp LH, Smith RP, Ritz WJ, Carlyn CJ, Michelsen PB.
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):299-304. PubMed ID: 15893901
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M, Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):162-71. PubMed ID: 20338711
    [Abstract] [Full Text] [Related]

  • 7. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W, Brasch J, German Society for Gynecology and Obstetrics, Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, German Society of Dermatology, the Board of German Dermatologists, German Speaking Mycological Society.
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [Abstract] [Full Text] [Related]

  • 8. Antifungal efficacy of propolis against fluconazole-resistant Candida glabrata isolates obtained from women with recurrent vulvovaginal candidiasis.
    Shokri H, Khosravi AR, Yalfani R.
    Int J Gynaecol Obstet; 2011 Aug; 114(2):158-9. PubMed ID: 21669419
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
    Asticcioli S, Sacco L, Daturi R, Matti C, Nucleo E, Zara F, Pagani L.
    New Microbiol; 2009 Apr; 32(2):199-204. PubMed ID: 19579700
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    González GM, Portillo OJ, Uscanga GI, Andrade SE, Robledo M, Rodríguez C, Elizondo M.
    J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
    Kiraz N, Oz Y, Dag I.
    J Chemother; 2010 Aug; 22(4):280-2. PubMed ID: 20685635
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.